Monitoring and Investigating Drug Diversion


Jay Anstine Keynote Speaker at Compliance key Inc. He is the President of Bluebird Healthlaw Partners, LLC. As a healthcare lawyer specializing in regulatory compliance, Mr. Anstine consults to physicians, senior management, and boards of directors on compliance programs and regulatory issues impacting operations.

Mr. Anstine's professional background includes working on the provider and the payer side of the marke....

Overview

This webinar will walk attendees through monitoring against drug diversion and investigating alleged diversions. More specifically, it will discuss the warning signs of diversion, common methods used to carry out diversion, potential organizational vulnerabilities, investigating a diversion case from beginning to end, and offer tips for safeguarding against diversion. To help highlight certain discussion points, Mr. Anstine will additionally cover selected real life cases of drug diversion that have occurred inside healthcare organizations by workforce members.

Why should you attend this webinar?

As prescription drug abuse has significantly increased over recent years in the United States, so too have reported cases of drug diversions by healthcare workers (clinical or administrative). Diversions can range from workforce members pocketing pills to injecting oneself and reusing supplies that later infect patients. As a consequence, how an organization monitors and investigates drug diversion will vary as well as the organization's public exposure, which also must be managed. This webinar is therefore designed help educate attendees on drug diversion issues and how to respond to suspected diversions.

Areas Covered in the Session:

  • What is drug diversion?
  • Trends in the rise of diversion cases.
  • Signs of potential diversion.
  • How to investigate suspected drug diversion.
  • Reporting obligations to government agencies.
  • Recent notable drug diversion cases.
  • Questions and answers

Who can Benefit:

The target audience for this presentation will be new-to-the-profession compliance officers or existing staff that have taken on a compliance officer function within their organization and have responsibility for investigating diversion of controlled substances in the organization.



Webinar Id: LSHCJA011

Training Options:

Duration: 90 mins

 06/27/2017

 10:00 AM PST | 01:00 PM EST

 Single Attendee: [Only for one participant]

 $179 (Live)                    $304 (Live + Recorded)

 Multiple Attendee: [For a group of 2-5 participants]

 $363 (Live)                    $488 (Live + Recorded)

 Corporate Attendee: [For a group of 6-10 Participants]

 $726 (Live)                    $945 (Live + Recorded)

 Recorded: [Six month unlimited access]

 $217(Single Attendee)  $599 (Unlimited Attendee)

Refund Policy
Upcoming Webinar of Jay Anstine
Tis the Season: Navigating the Compliance Challenges with Holiday Gifts
By: Jay Anstine
When: 11/15/2017 | 12.30 PM PST | 03.30 PM EST
Price: $179
Looking Inward: Assessing the Effectiveness of Your Compliance Program.
By: Jay Anstine
When: 10/11/2017 | 10.00 AM PST | 01.00 PM EST
Price: $179

More Webinar

Upcoming Webinar :Life Sciences and Healthcare
Navigating the Politics of Healthcare from the Compliance Role
By: Jay Anstine
When: 08/17/2017 | 10:00 AM PST | 01:00 PM EST
Price: $179
Business Continuity & Disaster Recovery
By: Angela Bazigos
When: 08/18/2017 | 10:00 AM PST | 01:00 PM EST
Price: $179

More Webinar

    
Copyright © 2017 Compliance Key . All Rights Reserved. Back to Top